Rights and permissions
About this article
Cite this article
MDX-H210 active in advanced HER2-positive prostate cancer. Inpharma Wkly. 1304, 6 (2001). https://doi.org/10.2165/00128413-200113040-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200113040-00013